**Question:** Drug of choice for MRSA

**Core Concept:** Methicillin-resistant Staphylococcus aureus (MRSA) is an antibiotic-resistant strain of Staphylococcus aureus that can cause serious infections in humans. Antibiotic treatment for MRSA infections is challenging due to its resistance mechanisms.

**Why the Correct Answer is Right:**
The correct answer is Vancomycin (Correct Answer: D). Vancomycin is an antibiotic that belongs to the glycopeptide class and is effective against Gram-positive bacteria, including MRSA. It works by inhibiting bacterial cell wall synthesis, specifically by binding to the D-Ala-D-Ala terminal of the peptidoglycan precursors, preventing cross-linking and leading to cell wall degradation.

**Why Each Wrong Option is Incorrect:**
A. Linezolid (Option A) is also a glycopeptide antibiotic, but it has reduced efficacy against MRSA due to its high affinity for penicillin-binding proteins (PBPs), which leads to the inhibition of protein synthesis rather than cell wall synthesis.

B. Clindamycin (Option B) is an antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. However, it is less effective against MRSA due to its poor penetration into biofilms and the presence of efflux pumps that export the drug out of the bacteria.

C. Tigecycline (Option C) is a glycopeptide antibiotic with activity against MRSA, but its use is limited by its poor tissue penetration and low oral bioavailability, making it less effective in treating systemic infections.

**Clinical Pearl / High-Yield Fact:**
Clinical pearl: In case of severe MRSA infections, consider combining vancomycin with another antibiotic, such as rifampicin or daptomycin, for better coverage and penetration into the infected tissue. This combination therapy enhances the overall efficacy and reduces the risk of resistance development.